Cyclosporine is an immunosuppressive agent used to treat organ rejection post-transplant. It also has uses in certain other autoimmune diseases.

**FDA approved Indications**

- In solid organ transplantation, it has clinical use to treat organ rejection in kidney, liver, and heart allogeneic transplants.

- In patients with rheumatoid arthritis, it is indicated when the disease has not adequately responded to methotrexate.

- For psoriasis, indications include the treatment of adult, nonimmunocompromised patients with severe, recalcitrant, plaque psoriasis who have not responded to at least one systemic therapy.

- In patients with amyotrophic lateral sclerosis (ALS or Lou Gehrig disease), cyclosporin is approved to treat amyotrophic lateral sclerosis and its variants.

- In nephrotic syndrome, it is indicated to treat focal segmental glomerulosclerosis not responding to corticosteroids.

- In individuals with graft vs. host disease (GVHD), it prevents and treats the disease.

- In the case of uveitis, cyclosporin is indicated for refractory posterior uveitis and Behcet disease.

**Non-FDA approved Indications**

- Allergic conjunctivitis, keratoconjunctivitis, Langerhans cells histiocytosis, ocular graft vs. host disease, autoimmune hepatitis, Duchenne muscular dystrophy, ulcerative colitis, pure red cell aplasia, and Henoch Schönlein purpura nephritis.